Laser Center

CLOSED FOR ENROLLMENT

Excessive Sweating

A Clinical Trial is currently underway to evaluate an investigational method for treating patients with axillary hyperhidrosis. If you have been diagnosed with or think you might have axillary hyperhidrosis, you may be eligible to participate in this clinical research study. In order to be able to participate in this study, you must meet certain study criteria.

Participants must over the age of 18 and comply with study instruction and follow up visits. Specific inclusion and exclusion criteria do apply.

You must be diagnosed with axillary hyperhidrosis
(excessive sweating of the armpit)
You must be 18 years of age or older
You must not be currently participating in another clinical study

Laser Hair Removal

A clinical research trial for laser hair removal of the axilla. In order to be able to participate in this study, you must meet certain study criteria.

• Healthy, adult, female, 18 years of age or older with skin type I-IV;
  
• Having at least one suitable treatment area for hair removal with brown hair;
  
• Able and willing to comply with the treatment/follow-up schedule and requirements;
  
• Able to read, understand and provide written Informed Consent.
  
• Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to market preference test enrollment and throughout the course of the study treatment.
  

• Showing symptoms of hormonal disorders, as per the Investigator?s discretion;
  
• Use of oral isotretinoin (Accutane?) within 6 months
  
• Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;
  
• History of keloid formation or poor wound healing in a previously injured skin area;
  
• Significant skin conditions affecting treated area or inflammatory skin conditions;
  
• Open laceration, abrasion, active cold sores or herpes sores on area to be treated;
  
• History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;
  
• Having a history of bleeding disorder or taking anticoagulation medications before the washout period, per the package insert, and at the physician?s discretion;
  
• Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated, personal history of melanoma;
  
• Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;
  
• Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;
  
• Tattoos in the treatment areas;
  
• Dysplastic nevi in the treatment areas;
  
• Participation in a study of another device or drug within 3 month prior to study enrollment or during this study, and as per the Investigator?s careful discretion, as long as not contradictory to any of the above criteria;
  
• Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
  
• Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study;
  
• Allergy or history of an allergy to any topical anesthetic used;
  
• Pregnant, expectation of pregnancy, postpartum (<3 months) or nursing (<6 weeks);
  
• History of livedo reticularis, an autoimmune vascular disease;
  
• Hypersensitivity at the treatment site to any agents, solutions, or gel used in the treatment (applies to ET handpiece only), if no alternative exists;
  

  ENROLLMENT:

  Currently CLOSED for enrollment

   
  
  

  Severe Nasolabial Folds (Smile Lines)

  
  

  Facial lines and wrinkles from diminished collagen layers can be injected with fillers under the surface of the skin which may temporarily restore a smoother appearance. These products injected into the dermis of the skin are called dermal fillers. A clinical research study is currently enrolling patients to treat moderate to severe wrinkles with an investigational dermal filler.

  Participants must over the age of 18 and comply with study instruction and follow up visits. Specific inclusion and exclusion criteria do apply.
  
  Further information available to email inquiries only. Please, No phone calls.

  ENROLLMENT:

  Currently closed for enrollment

   
  
  

  Wrinkle Treatment and Skin Laxity Study

  
  

  Eligible participants must:

  be in good heatlh
  be 19-60 years of age
  have mild to severe facial wrinkles or skin laxity
  accept the obligation to attend scheduled follow-up visits
  
  

  You may not participate in this study if you:

  have an implanted electronic device
  are or may be pregnant or breastfeeding
  have a medical contraindication
  are or have been a smoker within the last 10 years
  
  

  ENROLLMENT:

  Currently closed for enrollment

   
  
  

  Thermage Circumferential Thigh Study

  
  

  We are looking for 12 subjects to receive treatment to their thigh on May 5th & 6th. The ideal candidate will be a male or female, 21 - 65 years of age with no more than 5% variation in body weight in the prior year and noe more t han 20% over normal body weight. No previous procedures or surgeries to targeted thigh areas.

  Must comply with study instruction and follow up visits. Specific inclusion and exclusion criteria do apply. Further information available to email inquiries only. Please, No phone calls.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	5 visits total Baseline/Treatment, 1 month follow up, 2 month follow up, 4 month follow up, 6 month follow up

   
  
  

  Medlite C6 Q-Switched Nd: Yag Laser Therapy for the Treatment of Mild-Severe Facial Acne Vulgaris

  
  

  Randomized, single blind, split-faced study of the Q-Switched Nd: Yag Laser therapy in the treatment of mild to severe acne.

  Patients 12 years of age (with parental consent) or older, with mild to severe acne. The patient must be willing to comply with study instructions and return to the clinic for required visits. Specific inclusion and exclusion criteria do apply. Contact the office for further information.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	13 visits total Two times per week for six weeks Follow up visit at week ten

   
  
  

  Determination of Safety and Efficacy of the Candela Smoothbeam Laser for the Treatment of Periorobital Lax Skin (eyebags).

  
  

  Randomized, single blind, split-faced study of the Smoothbeam Laser in the treatment of loose eyelid skin and eye bags.

  Open to patients 35 years of age (in good health) or older, with loose eyelid skin and eye bags. The patient must be willing to comply with study instructions and return to the clinic for required visits. Specific inclusion and exclusion criteria do apply. Contact the office for further information.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	3-5 treatments 4 weeks apart 3 follow up visits

   
  
  

  Fractional Laser Technology for Treatment of Scarring.

  
  

  The primary objective of this study is to assess efficacy of the treatment and to confirm safety of the treatment. Open to subjects either male or female, between 18 to 75 years of age at the date of first treatment. Potential subjects must have moderate to severe surgical scars or stretch marks cannot have taken Accutane during the laser 12 months, cannot have a known allergy to lidocaine, no history of keloid scarring or atrophic dermatitis and no recent laser treatments or cosmetic procedures within the treatment area (in the laser 6 months), other inclusion/exclusion criteria does apply.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	3 treatments 7 follow up visits Photos at each visit

   
  
  

  Determination of Safety & Efficacy of the Candela 1310nm Diode Laser with Contact or Passive Air Cooling for Treatment of Skin Laxity.

  
  

  The primary objective of this study is to assess efficacy of the treatment on the face and neck and to confirm safety of the treatment. Open to subjects either male or female, between the age of 40 - 65 at the date of first treatment, with prominent skin laxity of the face and neck. Potential subjects cannot have had treatments with Botox or soft tissue fillers within the past 6 months or ablative resurfacing or deep chemical peel within the past 12 months other inclusion/exclusion criteria does apply.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	3 treatments 4-6 weeks apart 3 follow up visits: 1 month post tx 3 3 months post tx 3 6 months post tx 3 Photos at each visit

   
  
  

  Treatment of the Upper Arm Using the ThermaCool System

  
  

  A randomized study designed to determine if the ThermaCool System that is currently cleared by the Food and Drug Administration can safely and effectively improve the appearance of upper arm skin.

  Open to patients 40 to 70 years of age with laxity of the skin in the upper arm area. Must comply with study instruction and follow up visits. Specific inclusion and exclusion criteria do apply. Contact the office for further information.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	5 visits total Baseline/Treatment, 1 month follow up, 2 month follow up, 4 month follow up, 6 month follow up

   
  
  

  A Prospective, Single-Center Clinical Study of Non-Invasive Cooling of Subcutaneous Fat in Patients Undergoing Abdomnioplasty

  
  

  The purpose of this study is to assess the effects of cold exposure on the skin and the fatty tissue just beneath the skin.

  ENROLLMENT:	Currently closed for enrollment
  TREATMENT PROTOCOL:	The total duration of the study will be approximately 28 days

  
  
  

  Please contact Julie, our Study Coordinator, via email. Study Email